Gallagher Carol Giltner
Insider CIK 1329959 · ANAB Director · MLND Director · MRTX Director · TPTX Director · ATRA Director · PMVP Director · CERT Director · FLAC Director · TRXB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRXB TRex Bio, Inc. | A Award deriv | 2026-10-08 | 2026-10-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2025-06-10 | 2025-06-12 | 7,828 | — | $0 | 33,012 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2024-06-07 | 2024-06-10 | 67,500 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2024-06-07 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2024-03-31 | 2024-04-02 | 150,000 | — | $0 | 629,608 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 12,784 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 7,555 | — | $0 | 6,808 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,808 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 6,808 | $58.75 | $400.0K | 14,363 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2023-11-14 | 2023-11-15 | 90,980 | $0.31 | $28.2K | 459,418 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2023-11-13 | 2023-11-15 | 179,020 | $0.22 | $39.4K | 368,438 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 12,784 | — | $0 | 12,784 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-06-22 | 2023-06-23 | 7,555 | — | $0 | 7,555 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2023-05-31 | 2023-06-02 | 79,500 | — | $0 | 79,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2023-05-31 | 2023-06-02 | 57,000 | — | $0 | 189,418 | SEC↗ |
| FLAC Frazier Lifesciences Acqui | M Exercise deriv | 2022-11-22 | 2022-11-23 | 30,000 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2022-11-05 | 2022-11-08 | 39,000 | — | $0 | 39,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | G Gift deriv | 2022-11-05 | 2022-11-08 | 39,000 | — | $0 | 39,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | A Award deriv | 2022-11-04 | 2022-11-08 | 39,000 | — | $0 | 39,000 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 30,000 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 8,500 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | D To issuer deriv | 2022-08-17 | 2022-08-17 | 8,500 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2022-06-23 | 2022-06-27 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2022-06-23 | 2022-06-27 | 20,500 | — | $0 | 132,418 | SEC↗ |
| CERT Certara, Inc. | A Award | 2021-06-15 | 2021-06-16 | 7,059 | — | $0 | 7,059 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2021-06-08 | 2021-06-09 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2021-06-08 | 2021-06-09 | 11,000 | — | $0 | 111,818 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2021-06-02 | 2021-06-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2020-06-22 | 2020-06-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2020-06-16 | 2020-06-17 | 24,500 | — | $0 | 24,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2020-06-16 | 2020-06-17 | 8,000 | — | $0 | 100,818 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-06-15 | 2020-06-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| TPTX Turning Point Therapeutics | G Gift deriv | 2019-08-27 | 2020-06-17 | 30,000 | — | $0 | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | G Gift deriv | 2019-08-27 | 2020-06-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2019-07-24 | 2019-07-25 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2019-06-27 | 2019-07-01 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2019-06-27 | 2019-07-01 | 4,000 | — | $0 | 92,818 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2019-06-20 | 2019-06-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2019-01-15 | 2019-01-17 | 6,000 | — | $0 | 6,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award | 2018-12-07 | 2018-12-11 | 23,684 | — | $0 | 23,684 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award | 2018-12-07 | 2018-12-11 | 8,249 | — | $0 | 8,249 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-11-07 | 2018-11-07 | 21,374 | $36.38 | $777.6K | 88,818 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-06-18 | 2018-06-19 | 400 | $45.29 | $18.1K | 110,192 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-06-18 | 2018-06-19 | 2,100 | $44.68 | $93.8K | 110,592 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2018-06-14 | 2018-06-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2018-06-14 | 2018-06-18 | 1,500 | — | $0 | 112,692 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-05-16 | 2018-05-16 | 273 | $46.06 | $12.6K | 111,192 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2018-05-15 | 2018-05-16 | 545 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2018-05-15 | 2018-05-16 | 545 | — | $0 | 111,465 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2018-02-16 | 2018-02-20 | 1,183 | $46.50 | $55.0K | 110,920 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2018-02-15 | 2018-02-20 | 817 | — | $0 | 545 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2018-02-15 | 2018-02-20 | 1,548 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2018-02-15 | 2018-02-20 | 1,548 | — | $0 | 111,286 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2018-02-15 | 2018-02-20 | 817 | — | $0 | 112,103 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2018-02-02 | 2018-02-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-11-16 | 2017-11-17 | 1,184 | $14.20 | $16.8K | 109,738 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-11-15 | 2017-11-17 | 817 | — | $0 | 1,362 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-11-15 | 2017-11-17 | 1,549 | — | $0 | 1,548 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-11-15 | 2017-11-17 | 1,549 | — | $0 | 110,105 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-11-15 | 2017-11-17 | 817 | — | $0 | 110,922 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-08-16 | 2017-08-17 | 1,184 | $14.30 | $16.9K | 108,556 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-08-15 | 2017-08-17 | 1,548 | — | $0 | 3,097 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-08-15 | 2017-08-17 | 818 | — | $0 | 2,179 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-08-15 | 2017-08-17 | 818 | — | $0 | 109,740 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-08-15 | 2017-08-17 | 1,548 | — | $0 | 108,922 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-06-09 | 2017-06-12 | 1,000 | $13.15 | $13.2K | 107,374 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2017-06-08 | 2017-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2017-06-08 | 2017-06-12 | 5,000 | — | $0 | 108,374 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-05-16 | 2017-05-17 | 1,184 | $15.25 | $18.1K | 103,374 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-05-15 | 2017-05-17 | 817 | — | $0 | 2,997 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-05-15 | 2017-05-17 | 1,549 | — | $0 | 4,645 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-05-15 | 2017-05-17 | 1,549 | — | $0 | 103,741 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-05-15 | 2017-05-17 | 817 | — | $0 | 104,558 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2017-02-24 | 2017-02-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2017-02-16 | 2017-02-16 | 1,183 | $16.10 | $19.0K | 102,192 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-02-15 | 2017-02-16 | 817 | — | $0 | 3,814 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2017-02-15 | 2017-02-16 | 1,548 | — | $0 | 6,194 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-02-15 | 2017-02-16 | 1,548 | — | $0 | 102,558 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2017-02-15 | 2017-02-16 | 817 | — | $0 | 103,375 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 42,857 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 21,439 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 64,296 | — | $0 | 64,296 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2017-01-03 | 2017-01-05 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2017-01-03 | 2017-01-05 | 2,000 | — | $0 | 101,010 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-11-16 | 2016-11-17 | 1,184 | $19.35 | $22.9K | 99,010 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-11-15 | 2016-11-17 | 1,549 | — | $0 | 7,742 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-11-15 | 2016-11-17 | 817 | — | $0 | 4,631 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-11-15 | 2016-11-17 | 817 | — | $0 | 100,194 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-11-15 | 2016-11-17 | 1,549 | — | $0 | 99,377 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-08-15 | 2016-08-17 | 1,548 | — | $0 | 9,291 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-08-15 | 2016-08-17 | 818 | — | $0 | 5,448 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-08-15 | 2016-08-17 | 818 | — | $0 | 97,828 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-08-15 | 2016-08-17 | 1,548 | — | $0 | 97,010 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-05-18 | 2016-05-18 | 1,184 | $15.96 | $18.9K | 95,462 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-05-16 | 2016-05-18 | 1,549 | — | $0 | 10,839 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-05-16 | 2016-05-18 | 817 | — | $0 | 6,266 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-05-16 | 2016-05-18 | 817 | — | $0 | 96,646 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-05-16 | 2016-05-18 | 1,549 | — | $0 | 95,829 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2016-02-17 | 2016-02-18 | 1,183 | $16.30 | $19.3K | 94,280 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-02-16 | 2016-02-18 | 817 | — | $0 | 7,083 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2016-02-16 | 2016-02-18 | 1,548 | — | $0 | 12,388 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-02-16 | 2016-02-18 | 817 | — | $0 | 95,463 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2016-02-16 | 2016-02-18 | 1,548 | — | $0 | 94,646 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2016-01-04 | 2016-01-05 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-11-17 | 2015-11-18 | 1,184 | $31.10 | $36.8K | 93,098 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-11-16 | 2015-11-18 | 817 | — | $0 | 7,900 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-11-16 | 2015-11-18 | 1,549 | — | $0 | 13,936 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-11-16 | 2015-11-18 | 1,549 | — | $0 | 93,465 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-11-16 | 2015-11-18 | 817 | — | $0 | 94,282 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-24 | 2015-08-24 | 1,279 | $41.88 | $53.6K | 91,916 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-24 | 2015-08-24 | 2,736 | $40.67 | $111.3K | 93,195 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-24 | 2015-08-24 | 1,232 | $39.77 | $49.0K | 95,931 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-24 | 2015-08-24 | 627 | $38.44 | $24.1K | 97,163 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-21 | 2015-08-24 | 448 | $42.46 | $19.0K | 97,790 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-21 | 2015-08-24 | 5,426 | $41.65 | $226.0K | 98,238 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-20 | 2015-08-24 | 3,274 | $45.88 | $150.2K | 103,664 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-20 | 2015-08-24 | 600 | $44.08 | $26.4K | 106,938 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-20 | 2015-08-24 | 2,000 | $43.24 | $86.5K | 107,538 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-19 | 2015-08-19 | 4,375 | $47.98 | $209.9K | 111,038 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-19 | 2015-08-19 | 1,500 | $48.78 | $73.2K | 109,538 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2015-08-18 | 2015-08-19 | 5,764 | $49.38 | $284.6K | 115,413 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-08-17 | 2015-08-19 | 4,359 | — | $0 | 8,717 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-08-17 | 2015-08-19 | 44,871 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise deriv | 2015-08-17 | 2015-08-19 | 9,291 | — | $0 | 15,485 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-08-17 | 2015-08-19 | 44,871 | — | $0 | 107,527 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-08-17 | 2015-08-19 | 9,291 | — | $0 | 116,818 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | M Exercise | 2015-08-17 | 2015-08-19 | 4,359 | — | $0 | 121,177 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2015-02-18 | 2015-02-18 | 11,000 | $18.00 | $198.0K | 62,656 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2015-01-16 | 2015-01-21 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-23 | 22,500 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2014-10-21 | 2014-10-23 | 13,076 | — | $0 | 13,076 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion deriv | 2014-10-21 | 2014-10-23 | 10,975 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2014-10-21 | 2014-10-23 | 44,871 | — | $0 | 44,871 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award deriv | 2014-10-21 | 2014-10-23 | 24,776 | — | $0 | 24,776 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | P Buy | 2014-10-21 | 2014-10-23 | 18,181 | $11.00 | $200.0K | 51,656 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | C Conversion | 2014-10-21 | 2014-10-23 | 33,475 | — | $0 | 33,475 | SEC↗ |